Ying Lin

Ying joined Ensem Therapeutics from ChemPartner where she served as Senior Director of In Vitro Biology and managed a team of 60 scientists. Ying previously spent 10 years at Novartis Institute of Biomedical Research (China) where she served as Senior Investigator of lead discovery platform. She successfully delivered high quality small molecule hits, leads, and drug candidates for therapeutic targets including Cancer, Epigenetics and Liver diseases. Ying completed her Post-Doctoral at Texas A&M University, Department of Biochemistry and Biophysics, and holds a Ph.D. in Biochemistry from University of New Mexico.